| Understanding infectious complications in patients with lower risk myelodysplastic syndromes: a step towards improving survival |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia |
|
Haematologica |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
| Germline and somatic genetic landscape of pediatric myelodysplastic syndromes |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation |
|
Haematologica |
Aplastic Anemia |
| Treatment of lower-risk myelodysplastic syndromes |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Diagnosis of myelodysplastic syndromes: the classic and the novel |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Treatment of high-risk myelodysplastic syndromes |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Immunosuppression and Growth Factors for Severe Aplastic Anemia: New Data for Old Questions |
|
Haematologica |
Aplastic Anemia |
| Diagnosis of myelodysplastic syndromes: the classic and the novel |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Genome sequencing in the management of myelodysplastic syndromes and related disorders |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
